Drug Shortage Report for APO-DILTIAZ CD

Last updated on 2021-08-23 History
Report ID 134811
Drug Identification Number 02230998
Brand name APO-DILTIAZ CD
Common or Proper name DILTIAZ
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 180MG
Dosage form(s) CAPSULE (CONTROLLED-DELIVERY)
Route of administration ORAL ORAL
Packaging size 500 BTL
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-22
Estimated end date 2021-09-10
Actual end date 2021-08-20
Shortage status Resolved
Updated date 2021-08-23
Company comments 100 bottle format is available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2021-08-23 French Compare
v14 2021-08-23 English Compare
v13 2021-07-05 French Compare
v12 2021-07-05 English Compare
v11 2021-05-26 French Compare
v10 2021-05-26 English Compare
v9 2021-03-26 French Compare
v8 2021-03-26 English Compare
v7 2021-03-17 French Compare
v6 2021-03-17 English Compare
v5 2021-03-08 French Compare
v4 2021-03-08 French Compare
v3 2021-03-08 English Compare
v2 2021-02-26 French Compare
v1 2021-02-26 English Compare

Showing 1 to 15 of 15